CAR Consumables

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Chimeric antigen receptor (CAR) T cells have made a quantum leap in the treatment of blood and solid malignancies over the past few decades. As autologous T lymphocytes, CAR-T cells are designed to express antigen-binding regions of antibodies against tumor-associated antigens (TAAs). In the research process, a variety of techniques and experiments related to CART cells are involved. Correspondingly, CAR consumables are also an indispensable part. As a leading global provider of products and services in the field of CAR, Creative Biolabs offers a wide range of consumables related to CAR in addition to vectors, viruses, and cells closely related to CAR.

Fig.1 CAR-T cell structure. (Heyman, et al., 2019) Fig.1 CAR-T cell structure.¹

Our CAR Consumables

Cell culture consumables
These products are used in vitro cell growth and maintenance processes. These consumables are essential tools in CAR-T cell research. Creative Biolabs offers a wide range of cell culture consumables, including cell culture dishes, cell culture flasks, serological pipets and so on.
Validation test consumables
In chromatography or ELISA experiments, accessories are often needed to help you complete the experiment, such as HPLC columns, ELISA plates, etc. Creative Biolabs provides basic CAR lab consumables to meet your needs.
Endotoxin- free consumables
In experimental procedures, there is usually a requirement for endotoxin-free sterility. Creative Biolabs offers a range of endotoxin- free consumables to achieve your specific demanding and offer high-quality experimental results. Our endotoxin- free consumables include: endotoxin-free vials, endotoxin-free tubes, endotoxin removing gel and so on.
Others

Applications

Cell culture
HPLC
ELISA
IHC
Functional assay
Others

If you have any needs for CAR consumable products, please contact us immediately. Our professionals will assist you and recommend suitable products.

Reference

Heyman.; et al. "himeric antigen receptor T cell therapy for solid tumors: current status, obstacles and future strategies." Cancers. (2019) 11,2 191.

Key Updates

NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER

NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION

NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY

NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION